Compare OMCL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMCL | AORT |
|---|---|---|
| Founded | 1992 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 2001 | 1993 |
| Metric | OMCL | AORT |
|---|---|---|
| Price | $46.27 | $40.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $51.50 | $49.36 |
| AVG Volume (30 Days) | ★ 525.2K | 312.9K |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $1,177,740,000.00 | $422,646,000.00 |
| Revenue This Year | $8.61 | $15.97 |
| Revenue Next Year | $4.30 | $10.96 |
| P/E Ratio | $109.75 | ★ N/A |
| Revenue Growth | ★ 10.67 | 9.81 |
| 52 Week Low | $22.66 | $21.97 |
| 52 Week High | $55.00 | $48.25 |
| Indicator | OMCL | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 41.58 | 32.25 |
| Support Level | $45.10 | $39.50 |
| Resistance Level | $50.14 | $41.97 |
| Average True Range (ATR) | 1.72 | 1.40 |
| MACD | -0.80 | -0.19 |
| Stochastic Oscillator | 18.25 | 12.86 |
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.